A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2011
10/18/2011	US8039026 Methods for treating skin pigmentation
10/18/2011	US8039010 Glycolic acid-lactic acid copolymer; biocompatible; biodegradable; RNA interference; inhibitors of vascular endothelial growth factor (VEGF); ocular disorders
10/18/2011	US8039000 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
10/18/2011	US8038995 Human N-type calcium channel isoform and uses thereof
10/18/2011	US8038990 Compositions and methods for the prevention and removal of biofilms on inert and biological surfaces
10/18/2011	US8038665 Methods of administering a material into a patient for dermal enhancement
10/18/2011	CA2530774C Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
10/18/2011	CA2506329C Candida kefyr cytosine deaminase
10/18/2011	CA2494541C Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
10/18/2011	CA2470643C Cleavable reagents for specific delivery to disease sites
10/18/2011	CA2465156C Il-21 antagonists
10/18/2011	CA2446189C Peptides and related molecules that bind to tall-1
10/18/2011	CA2391843C Hcv vaccine compositions
10/18/2011	CA2381708C Immunogenic protein against piscirickettsia salmonis
10/18/2011	CA2372099C Antiviral agent in the form of nose drops
10/18/2011	CA2311492C Vaccines with an ltb adjuvant
10/18/2011	CA2252986C Process for preparing functional recombinant tissue factor
10/18/2011	CA2228944C Liposomal phosphodiester, phosphorothioate, and p-ethoxy oligonucleotides
10/18/2011	CA2226575C Stabile isotonic lyophilized protein formulation
10/18/2011	CA2221682C Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent
10/18/2011	CA2213833C Vascular endothelial cell growth factor antagonists
10/13/2011	WO2011127482A2 Modulation of histone deacetylases for the treatment of metabolic disease, methods and compositions related thereto
10/13/2011	WO2011127458A2 Systems and methods of cell activated, controlled release delivery of growth factors for tissue repair and regeneration
10/13/2011	WO2011127426A1 Methods for modeling protein stability
10/13/2011	WO2011127418A1 Btnl9 proteins, nucleic acids, and antibodies and uses thereof
10/13/2011	WO2011127405A1 Methods and compositions for enhanced delivery of compounds
10/13/2011	WO2011127393A2 Variants of ancestral uricases and uses thereof
10/13/2011	WO2011127302A2 Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
10/13/2011	WO2011127297A1 Method of treating tumor resistant to herceptin or paclitaxel using foxm1 inhibitors and detecting same
10/13/2011	WO2011127288A2 Methods and uses of nur77 and nur77 agonists to modulate macrophages and monocytes, and treat inflammation, inflammatory disease and cardiovascular disease
10/13/2011	WO2011127256A1 Protein-poly(2-oxazoline) conjugates for enhanced cellular delivery and transport across biological barriers
10/13/2011	WO2011127210A1 Targeted delivery of nucleic acids
10/13/2011	WO2011127202A2 Methods for identifying and using inhibitors of casein kinase 1 epsilon isoform for inhibiting the growth and/or proliferation of myc-driven tumor cells
10/13/2011	WO2011126882A2 Therapeutic peptides and their derivatives and therapeutic uses thereof
10/13/2011	WO2011126873A2 Proteases for degrading gluten
10/13/2011	WO2011126864A2 Cancer treatment with recombinant vector
10/13/2011	WO2011126853A2 Prevention or delay of onset of oral mucositis
10/13/2011	WO2011126833A2 Anti-inflammatory factors
10/13/2011	WO2011126804A1 Uses of chec peptides to treat neurological and cardiovascular diseases and disorders
10/13/2011	WO2011126790A1 Methods and compositions for inducing brown adipogenesis
10/13/2011	WO2011126054A1 Physiologically active peptides
10/13/2011	WO2011126010A1 Cancer cell-specific cell-penetrating peptide and use thereof
10/13/2011	WO2011125331A1 Metal salen complex derivative and process for production thereof
10/13/2011	WO2011125034A1 Preparation of recombinant human plasma phospholipid transfer protein (pltp) from the milk of transgenic animals
10/13/2011	WO2011125029A1 THERAPEUTIC USE OF THE ß2m PROTEIN
10/13/2011	WO2011124685A1 Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
10/13/2011	WO2011124063A1 Polypeptides for the treatment or prevention of cancers and uses thereof
10/13/2011	WO2011124031A1 Polypeptide conjugate of paclitaxel or docetaxel
10/13/2011	WO2011123945A1 Compostions, methods and uses for treating respiratory syncytial virus infection
10/13/2011	WO2011123943A1 Methods for treating disorders of the gastrointestinal tract using a glp-1 agonist
10/13/2011	WO2011123903A1 Chemokine receptor heteromultimers, compounds that bind thereto and uses thereof
10/13/2011	WO2011103583A3 Methods and compositions related to anti-angiogenic peptides
10/13/2011	WO2011091304A9 Delivery system for diagnostic and therapeutic agents
10/13/2011	WO2011089250A3 Stable growth hormone compounds
10/13/2011	WO2011088123A3 Wnt antagonists and methods of treatment and screening
10/13/2011	WO2011087857A3 Compositions and methods for treating obesity and diabetes
10/13/2011	WO2011084808A3 Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases
10/13/2011	WO2011083114A3 Serine hydrolase formulation
10/13/2011	WO2011072216A9 Treatment methods utilizing stem cell mobilizers and immunosuppressive agents
10/13/2011	WO2011071927A3 Treatments for gastrointestinal disorders
10/13/2011	WO2011063419A3 Lipopeptide compositions and related methods
10/13/2011	WO2011060242A3 Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
10/13/2011	WO2011057249A3 Treatment of heart disease
10/13/2011	WO2011056972A9 Compositions and methods of treating a t cell mediated disorder
10/13/2011	WO2011047794A3 Medical utility of glycan-binding proteins and glycans
10/13/2011	WO2011041483A9 Use of botulinum neurotoxin to treat substance addictions
10/13/2011	WO2011034951A3 Assisted enzyme replacement therapy
10/13/2011	WO2010001417A3 Use of plant-derived recombinant growth factors in skin care
10/13/2011	US20110251267 Methods of using polynucleotides encoding truncated glial cell line-derived neurotrophic factor
10/13/2011	US20110251140 Peptide antagonist of interleukin-15 activity
10/13/2011	US20110251139 Treatment of inflammatory bowel diseases with mammal beta defensins
10/13/2011	US20110251138 Lipoic acid metabolite conjugate: preparation and their therapeutic effect
10/13/2011	US20110251137 Gamma-polyglutamic acid-based ocular irrigating solutions
10/13/2011	US20110251136 Glue composition for lung volume reduction
10/13/2011	US20110251135 Inhibitors of peritoneal seeding of cancer cells
10/13/2011	US20110251134 Combination of (a) a dna toposomerase inhibitor and (b) an iap inhibitor
10/13/2011	US20110251133 Blockade of gamma-secretase activity to promote myelination by oligodendrocytes
10/13/2011	US20110251132 Treatment with a pharmaceutical composition comprising manf2 nucleic acid
10/13/2011	US20110251131 Deuterated 2-amino-3-hydroxypropanoic acid derivatives
10/13/2011	US20110251130 Methods and Compositions for Promoting Bone Growth
10/13/2011	US20110251129 Rheumatoid arthritis-preventive agent for oral intake
10/13/2011	US20110251128 THYMOSIN Beta4 PEPTIDES PROMOTE TISSUE REGENERATION
10/13/2011	US20110251127 Inactivation of infectious agents in plasma proteins by extreme pressure
10/13/2011	US20110251126 Intestinal treatment
10/13/2011	US20110251125 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
10/13/2011	US20110251124 Regulation of mineral and skeletal metabolism
10/13/2011	US20110251123 Oral pharmaceutical composition of desmopressin
10/13/2011	US20110251122 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
10/13/2011	US20110251121 Use of cysteine-rich whey derived protein in patients receiving chemotherapy and/or radiotherapy to improve patient survival
10/13/2011	US20110251120 Antimicrobial Peptides and Methods of Identifying the Same
10/13/2011	US20110250297 Treatment of Hyperproliferative Disorders Using Cardiac Glycosides
10/13/2011	US20110250284 Nanoparticles for Use as Synthetic Platelets and Therapeutic Agent Delivery Vehicles
10/13/2011	US20110250283 Pentablock Polymers
10/13/2011	US20110250268 Compositions and Methods for Inhibiting Gastric Acid Secretion
10/13/2011	US20110250265 Vaccine Preparation for Neospora Caninum Infection
10/13/2011	US20110250261 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
10/13/2011	US20110250255 Drug coated stent with endosome-disrupting conjugate
10/13/2011	US20110250243 Nanoparticle compositions
10/13/2011	US20110250240 Immune enhancing compositions and methods of use thereof
10/13/2011	US20110250238 System for the colon delivery of drugs subject to enzyme degradation and/or poorly absorbed in the gastrointestinal tract

1 ... 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 ... 3163